Horizon Pharma 21.4M share Spot Secondary priced at $3.50 The deal size was increased to 21.4M shares from 15.3M shares. Cowen, JMP Securities and Stifel Nicolaus acted as joint book running managers for the offering.
Horizon Pharma files to sell 11.66M shares for existing holders Horizon Pharma announced a proposed underwritten secondary offering of 11.66M of its ordinary shares held by certain of its existing shareholders. Morgan Stanley, Citigroup, Cowen and Jefferies are acting as joint book-running managers for this offering. JMP Securities is acting as financial advisor for this offering.